We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$158M
AUM Growth
-$435M
Cap. Flow
-$425M
Cap. Flow %
-268.84%
Top 10 Hldgs %
51.56%
Holding
73
New
22
Increased
6
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$3.42M
2
MASI
Masimo
MASI
+$3.29M
3
ICUI icon
ICU Medical
ICUI
+$3.09M
4
BRKR icon
Bruker
BRKR
+$2.45M
5
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$1.81M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$33.3M
2
LYRA
LYRA THERAPEUTICS INC
LYRA
+$8.79M
3
DXCM icon
DexCom
DXCM
+$4.16M
4
VKTX icon
Viking Therapeutics
VKTX
+$3.27M
5
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$2.86M

Sector Composition

Rank Sector Weight
1 Healthcare 48.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATEC icon
26
Alphatec Holdings
ATEC
$1.45B
$2.08M 1.32%
199,000
-121,054
-38% -$1.41M
BRKR icon
27
Bruker
BRKR
$8.69B
$2.07M 1.31%
+32,500
New +$2.45M
DHR icon
28
PUT
Danaher
DHR
$146B
$1.87M 1.19%
+7,500
New +$1.89M
CUTR
29
DELISTED
Cutera, Inc.
CUTR
$1.76M 1.11%
1,165,799
+87,072
+8% +$175K
TNDM icon
30
Tandem Diabetes Care
TNDM
$1.63B
$1.63M 1.03%
40,500
-2,000
-5% -$83.4K
BVS icon
31
Bioventus
BVS
$1.16B
$1.61M 1.02%
+280,000
New +$1.54M
IMDX
32
Insight Molecular Diagnostics
IMDX
$143M
$1.46M 0.92%
495,345
-28,583
-5% -$78.6K
STAA icon
33
CALL
STAAR Surgical
STAA
$1.24B
$1.43M 0.9%
+30,000
New +$1.31M
STAA icon
34
STAAR Surgical
STAA
$1.24B
$1.43M 0.9%
+30,000
New +$1.31M
ZIMV
35
DELISTED
ZimVie
ZIMV
$1.28M 0.81%
70,000
-3,095
-4% -$50.7K
NSPR icon
36
InspireMD
NSPR
$39.9M
$1.12M 0.71%
450,517
– –
SOLV icon
37
PUT
Solventum
SOLV
$14.3B
$1.11M 0.7%
+21,000
New +$1.27M
STE icon
38
PUT
Steris
STE
$23.2B
$1.1M 0.69%
+5,000
New +$1.09M
INMD icon
39
PUT
InMode
INMD
$870M
$1.09M 0.69%
60,000
-1,600
-3% -$29.4K
PEN icon
40
PUT
Penumbra
PEN
$12.9B
$1.08M 0.68%
+6,000
New +$1.2M
MGX icon
41
Metagenomi Therapeutics
MGX
$45.6M
$1.04M 0.66%
270,618
-190,665
-41% -$1.31M
ELAN icon
42
Elanco Animal Health
ELAN
$11.4B
$817K 0.52%
56,603
-136,647
-71% -$2.18M
GEHC icon
43
PUT
GE HealthCare
GEHC
$32.9B
$779K 0.49%
+10,000
New +$816K
TWST icon
44
Twist Bioscience
TWST
$7.72B
$493K 0.31%
+10,000
New +$408K
NARI
45
DELISTED
Inari Medical, Inc. Common Stock
NARI
$482K 0.3%
+10,000
New +$443K
ENOV icon
46
PUT
Enovis
ENOV
$1.42B
$362K 0.23%
+8,000
New +$415K
WGS icon
47
GeneDx Holdings
WGS
$2.44B
$261K 0.17%
+10,000
New +$190K
TALKW
48
DELISTED
Talkspace Inc Warrant
TALKW
$23.9K 0.02%
238,500
-139,500
-37% -$23.9K
MAPSW
49
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$2.52K ﹤0.01%
50,000
– –
BAX icon
50
Baxter International
BAX
$14.3B
– –
-30,000
Closed -$1.28M
1
2
3

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Pura Vida Investments held 73 positions worth $158M, down 73% from $593M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments withdrew a net $425M in Q2 2024, closing 24 positions and reducing 19 holdings. Its most notable exit was Exact Sciences, an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 24% a quarter earlier.

Against the trend, Pura Vida Investments opened a new position in Castle Biosciences worth $3.34M.

  • Pura Vida Investments's largest Q2 2024 buy was Castle Biosciences: 153,386 shares worth $3.34M.
  • Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q2 2024, an estimated $1.81M increase.
  • Pura Vida Investments's biggest Q2 2024 reduction was Elanco Animal Health, cutting an estimated $2.18M.
  • Pura Vida Investments fully exited Exact Sciences in Q2 2024, selling an estimated $33.3M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $158M portfolio in Q2 2024.
  • Pura Vida Investments opened 22 new positions and closed 24 in Q2 2024.
  • Pura Vida Investments's portfolio value fell 73% quarter-over-quarter to $158M.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.